168 related articles for article (PubMed ID: 8813446)
1. von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis.
Blann AD; Waite MA
Coron Artery Dis; 1996 Feb; 7(2):143-7. PubMed ID: 8813446
[TBL] [Abstract][Full Text] [Related]
2. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension.
Blann AD; Tse W; Maxwell SJ; Waite MA
J Hypertens; 1994 Aug; 12(8):925-8. PubMed ID: 7529277
[TBL] [Abstract][Full Text] [Related]
4. Von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease.
Blann AD; Davis A; Miller JP; McCollum CN
Am J Hematol; 1997 May; 55(1):15-23. PubMed ID: 9136912
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia.
Blann AD; Miller JP; McCollum CN
Atherosclerosis; 1997 Jul; 132(2):151-6. PubMed ID: 9242960
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of the TGF-beta receptor are increased in atherosclerosis.
Blann AD; Wang JM; Wilson PB; Kumar S
Atherosclerosis; 1996 Feb; 120(1-2):221-6. PubMed ID: 8645363
[TBL] [Abstract][Full Text] [Related]
7. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin.
Verhaar MC; Beutler JJ; Gaillard CA; Koomans HA; Fijnheer R; Rabelink TJ
J Hypertens; 1998 Jan; 16(1):45-50. PubMed ID: 9533416
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
9. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
[TBL] [Abstract][Full Text] [Related]
12. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Felmeden DC; Blann AD; Spencer CG; Beevers DG; Lip GY
Blood Coagul Fibrinolysis; 2003 Jul; 14(5):425-31. PubMed ID: 12851527
[TBL] [Abstract][Full Text] [Related]
13. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
Boos CJ; Balakrishnan B; Lip GY
Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
[TBL] [Abstract][Full Text] [Related]
14. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
[TBL] [Abstract][Full Text] [Related]
15. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.
De Caterina R; Basta G; Lazzerini G; Dell'Omo G; Petrucci R; Morale M; Carmassi F; Pedrinelli R
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2646-54. PubMed ID: 9409238
[TBL] [Abstract][Full Text] [Related]
16. Soluble P-selectin in hyperlipidaemia with and without symptomatic vascular disease: relationship with von Willebrand factor.
Blann AD; Goode GK; Miller JP; McCollum CN
Blood Coagul Fibrinolysis; 1997 Apr; 8(3):200-4. PubMed ID: 9167022
[TBL] [Abstract][Full Text] [Related]
17. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
[TBL] [Abstract][Full Text] [Related]
18. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
Ferri C; Desideri G; Baldoncini R; Bellini C; De Angelis C; Mazzocchi C; Santucci A
Diabetes; 1998 Apr; 47(4):660-7. PubMed ID: 9568701
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
[TBL] [Abstract][Full Text] [Related]
20. [Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy].
Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Aschermann M; Horký K
Vnitr Lek; 2002 Aug; 48(8):718-23. PubMed ID: 12425201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
